Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis

BACKGROUND: Serum neurofilament light chain (sNfL) is a promising biomarker to complement the decision-making process in multiple sclerosis (MS) patients. However, although sNfL levels are able to detect disease activity and to predict future disability, the growing evidence has not yet been transla...

Descripción completa

Detalles Bibliográficos
Autores principales: Engel, Sinah, Protopapa, Maria, Steffen, Falk, Papanastasiou, Vakis, Nicolaou, Christoforos, Protopapas, Michalis, Zipp, Frauke, Bittner, Stefan, Luessi, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060778/
https://www.ncbi.nlm.nih.gov/pubmed/33959194
http://dx.doi.org/10.1177/17562864211001977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060778/
https://www.ncbi.nlm.nih.gov/pubmed/33959194
http://dx.doi.org/10.1177/17562864211001977

Ejemplares similares